Inadequacy of Investigations, Root cause
Laurus Synthesis was issued an Untitled Letter by USFDA in May 2024, following critical observations
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Laurus Synthesis was issued an Untitled Letter by USFDA in May 2024, following critical observations
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators
Laurus, Visakh (India) was issued USFDA 483 with five (5) observations following USFDA inspection by
Laurus, Visakh was issued USFDA 483 with five (5) observations following USFDA inspection by investigators
USFDA inspected Laurus Synthesis, Visakh facility in India (FEI: 3011524794) in Dec 2023 by investigators